Suzhou Basecare Medical Corporation Limited
2170.HK
Get informed when a big investor buys or sells
+ FollowMarket Cap$344.64M
Close$
Share Statistics
| Market cap | $344.64 Million |
|---|---|
| Enterprise Value | $313.17 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.82 |
| Beta | 0.04 |
| Outstanding Shares | 273,526,597 |
Return
| Return on Equity | -20.12% |
|---|---|
| Return on Assets | -13.06% |
| Return on Invested Capital | -12.53% |
Valuation & Multiples
| P/E Ratio | -1.68 |
|---|---|
| PEG | 4.12 |
| Price to Sales | - |
| Price to Book Ratio | 0.43 |
| Enterprise Value to Revenue | 1.2 |
| Enterprise Value to EBIT | -2.16 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 1.09 |
| Debt to Equity | 0.4 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 28, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$74.35 M
Average shareholder expectationNext Earnings Call
Expected Date
April 1, 2027
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Suzhou Basecare Medical Corporation Limited
388 employees
CEO: Bo Liang Suzhou Basecare Medical Corporation Limited, an investment holding company established in Suzhou, China, in 2010, focuses its business activities within the People's Republic of China. The company primarily engages in the research, devel...